Latanoprost Teva Sante (Latanoprost)

Latanoprost is a prostaglandin F‑type receptor agonist. It remodels the extracellular matrix in the ciliary body, enhancing uveoscleral outflow of aqueous humor, which leads to a decrease in intraocular pressure.

The dosing regimen for Latanoprost Teva Sante is determined by the prescribing ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing should follow the prescriber’s instructions.

Latanoprost is classified as Pregnancy Category C, indicating that it should be used only if the potential benefit justifies the potential risk to the fetus. Limited data are available for breastfeeding; therefore, caution is advised and a healthcare professional should be consulted.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally provides greater intraocular pressure reduction with once‑daily dosing compared with beta‑blockers or carbonic anhydrase inhibitors. It is often preferred for its efficacy and convenient dosing schedule, though individual response may vary.

Latanoprost eye drops should be stored at room temperature, below 25 °C, in the original container. Protect the product from light and moisture, and keep the cap tightly closed when not in use.

The medication is applied as an ocular solution. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and place a single drop into the conjunctival sac of the prescribed eye(s). Avoid touching the tip of the bottle to the eye or any surface.

Serious adverse events, though rare, include severe allergic reactions, corneal ulceration, marked hypotony (very low intraocular pressure), and acute uveitis. Patients should seek immediate medical attention if they experience sudden eye pain, vision loss, or signs of infection.

Latanoprost is contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation. It should also be avoided in individuals with active ocular infections or inflammation until these conditions are resolved.